[PDF][PDF] Infection with SARS-CoV-2 in pregnancy. Information and proposed care. CNGOF

…, P Deruelle, C Huissoud, X Lescure… - … . Obstet. Fertil. Senol, 2020 - reseau-naissance.fr
Prematurity INSERM U1016, Institut IMAGINE 11. CNGOF, 91, boulevard de Sébastopol,
75002 Paris, France. 12. Infection Control Unit, Bichat University Hospital, Assistance Publique-…

[HTML][HTML] Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity

…, B Terrier, F Pène, J Ghosn, X Lescure… - Nature …, 2021 - nature.com
Immune system dysfunction is paramount in coronavirus disease 2019 (COVID-19) severity
and fatality rate. Mucosal-associated invariant T (MAIT) cells are innate-like T cells involved …

Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo …

…, X DUVAL, N HOUHOU, J Véronique, X LESCURE… - The Lancet, 2021 - thelancet.com
Background Shortening the duration of antibiotic therapy for patients admitted to hospital
with community-acquired pneumonia should help reduce antibiotic consumption and thus …

Infection par le SARS-CoV-2 chez les femmes enceintes: état des connaissances et proposition de prise en charge par CNGOF

…, J Sibiude, P Deruelle, C Huissoud, X Lescure… - … obstétrique fertilité & …, 2020 - Elsevier
Un nouveau coronavirus (SARS-CoV-2) mis en évidence en fin d’année 2019 en Chine se
diffuse à travers tous les continents. Le plus souvent à l’origine d’un syndrome infectieux …

No evidence of clinical efficacy of hydroxychloroquine in patients hospitalised for COVID-19 infection and requiring oxygen: results of a study using routinely collected …

…, S Gallien, R Lepeule, TA Szwebel, X Lescure… - medrxiv, 2020 - medrxiv.org
Background Treatments are urgently needed to prevent respiratory failure and deaths from
coronavirus disease 2019 (COVID-19). Hydroxychloroquine (HCQ) has received worldwide …

Vaccine education of medical students: a nationwide cross-sectional survey

…, M Etienne, E Faure, V Le Moing, X Lescure… - American journal of …, 2017 - Elsevier
Physicians play a primary role in vaccination of the population. Strong initial training of
medical students is therefore essential to enable them to fulfill this role. This cross-sectional …

Prevention of SARS-CoV-2 transmission during a large, live, indoor gathering (SPRING): a non-inferiority, randomised, controlled trial

…, A Olivier, C Poyart, J Le Goff, X Lescure… - The Lancet Infectious …, 2022 - thelancet.com
Background Mass indoor gatherings were banned in early 2020 to prevent the spread of
SARS-CoV-2. We aimed to assess, under controlled conditions, whether infection rates among …

[HTML][HTML] Covidom, a telesurveillance solution for home monitoring patients with COVID-19

Y Yordanov, A Dechartres, X Lescure, C Apra… - Journal of Medical …, 2020 - jmir.org
In a matter of months, COVID-19 has escalated from a cluster of cases in Wuhan, China, to
a global pandemic. As the number of patients with COVID-19 grew, solutions for the home …

[HTML][HTML] Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the …

…, K Lacombe, A Mekinian, H Gros, X Lescure… - …, 2022 - thelancet.com
Background In moderate-to-severe COVID-19 pneumonia, dexamethasone (DEX) and
tocilizumab (TCZ) reduce the occurrence of death and ventilatory support. We investigated the …

COVID-19 convalescent plasma to treat hospitalised COVID-19 patients with or without underlying immunodeficiency: a randomized trial

…, P Morel, O Hermine, V Pourcher, M Michel, X Lescure… - MedRxiv, 2022 - medrxiv.org
Objectives Efficacy of convalescent plasma in COVID-19 pneumonia (CPP) is uncertain,
especially in immunocompromised patients. CORIMUNO-CORIPLASM is an open-label, …